Donor cells train body to fight cancer in advanced colon cancer trial
Disease control
Completed
This study tested an experimental immunotherapy called STIMVAX for people with advanced colorectal cancer that had stopped responding to two previous chemotherapy treatments. The treatment uses specially prepared immune cells from healthy donors to try to teach the patient's own …
Phase: PHASE2 • Sponsor: Mirror Biologics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC